Siirry suoraan sisältöön
A Novel Chemotherapeutic Drug L-Lysine against Cancer Therapy- A Research-Based Study
Tallenna

A Novel Chemotherapeutic Drug L-Lysine against Cancer Therapy- A Research-Based Study

"A Novel Chemotherapeutic Drug Poly-L-Lysine against Cancer Therapy - A Research based Study" offers a fresh perspective on cancer therapy. This research-based study delves into the potential of L-lysine as a novel chemotherapeutic drug that could revolutionize cancer treatment. The authors present the results of their studies which showcase Poly-L-lysine's anti-angiogenesis properties and its potential in treating angiogenesis-related diseases. The book features eleven comprehensive chapters that provide an in-depth analysis of the research including the apoptotic and anticancer effects of L-lysine in mice models as well as its anti-proliferative and antiangiogenic properties. At the same time the book shares fascinating insights about the history of cancer and the medical community's ongoing efforts to find a cure.

A Novel Chemotherapeutic Drug Poly-L-Lysine against Cancer Therapy - A Research based Study" is a must-read for anyone interested in the latest advancements in cancer research and the future of cancer therapy.

ISBN
9789390211784
Kieli
englanti
Paino
310 grammaa
Julkaisupäivä
3.2.2024
Kustantaja
PharmaMed Press
Sivumäärä
204